UTICA, N.Y. — ConMed Corp. (NASDAQ: CNMD), a Utica–based surgical-device maker, had added two health-care executives to its board of directors.
The addition of David Bronson and John Workman are “effective immediately,” ConMed said in a news release issued Wednesday.
Bronson is currently director and audit-committee chair of Lenexa, Kansas–based AxelaCare, Inc. and a director and a member of the audit committee of Louisville, Kentucky–based Labsco, Inc. (Laboratory Supply Co.).
Bronson previously was executive vice president and CFO of Jacksonville, Florida–based PSS World Medical, Inc. from 2002 until McKesson Corp. acquired the firm in 2013, ConMed said.
Workman is currently board chairman and audit-committee chair of Minneapolis, Minnesota–based Universal Hospital Services and a director and audit-committee chair of Oak Brook, Illinois–based Federal Signal Corp. (NYSE: FSS), according to the ConMed news release.
He previously was CEO of Cincinnati, Ohio–based Omnicare, Inc. (NYSE: OCR) from 2012 to 2014, president and CFO from 2011 to 2012, and executive vice president and CFO from 2009 to 2010.
Mark Tryniski, chairman of the ConMed board of directors, called Bronson and Workman “outstanding additions” to the board.
“They both have extensive experience leading sophisticated health care organizations, executing successful turnarounds, and improving shareholder returns. Their impressive track records will make them vital contributors in guiding ConMed’s growth strategy,” Tryniski said in the release.
Contact Reinhardt at ereinhardt@cnybj.com
